Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: 501.88M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: May 11, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2023 March 16, 2023 -0.6 / -1.5656.18M / 15.27MBeat! November 30, 2022 - / -1.88- / 17.67MNovember 7, 2022 -1.76 / -1.7713.41M / 12.37MBeat! August 10, 2022 -2.02 / -2.1513.48M / 16.53Mview more
Historical Data Date Price Open High Low Vol Change ER Mar 28, 2022 17.98 17.61 18.27
17.61
34.70K 2.74% Mar 25, 2022 17.50 18.16 18.16
16.83
340.67K -3.42% Mar 24, 2022 18.12 17.04 18.16
16.80
343.96K 7.03% Mar 23, 2022 16.93 16.96 18.06
16.82
381.22K -1.28% Mar 22, 2022 17.15 16.31 17.47
15.49
715.57K 5.28% Mar 21, 2022 16.29 16.06 17.15
15.74
996.18K -0.06% Mar 18, 2022 16.30 14.52 16.34
14.52
1.01M 9.32% Mar 17, 2022 14.91 14.09 14.91
13.77
785.60K 6.65% Mar 16, 2022 13.98 12.53 14.02
12.33
906.19K 14.59% Mar 15, 2022 12.20 11.61 12.21
11.43
213.32K 4.54% view more
TSVT
More profiles and info about the company News
2seventy bio GAAP EPS of -$1.76 beats by $0.09, revenue of $13.4M beats by $1.03M seekingalpha.com Nov 8, 2022 6:00 am
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress finance.yahoo.com Nov 7, 2022 4:05 pm
2seventy bio and JW Therapeutics Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies finance.yahoo.com Oct 27, 2022 7:00 am
2seventy bio to Participate in Upcoming Investor Conferences finance.yahoo.com Aug 31, 2022 7:30 am 2seventy bio GAAP EPS of -$2.02 misses by $0.09, revenue of $13.48M misses by $3.04M seekingalpha.com Aug 10, 2022 8:07 pm Bristol Myers, 2seventy bio score trial win for multiple myeloma candidate seekingalpha.com Aug 10, 2022 7:16 pm
Will 2seventy bio (NASDAQ:TSVT) Spend Its Cash Wisely? finance.yahoo.com Aug 4, 2022 7:02 am
A 2seventy bio, Inc. (NASDAQ:TSVT) insider increased their holdings by 251% last year finance.yahoo.com Jul 4, 2022 3:30 pm
2seventy bio Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress finance.yahoo.com Mar 22, 2022 7:00 am
Do Institutions Own 2seventy bio, Inc. (NASDAQ:TSVT) Shares? finance.yahoo.com Feb 11, 2022 9:58 am
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer finance.yahoo.com Jan 26, 2022 8:00 am
2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach finance.yahoo.com Jan 6, 2022 7:00 am
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress finance.yahoo.com Aug 10, 2022 6:50 am Arcellx named new buy at Canaccord Genuity on multiple myeloma candidate seekingalpha.com Jul 21, 2022 12:18 am Morgan Stanley updates biotechs with negative enterprise values & 2022 catalysts seekingalpha.com May 31, 2022 9:06 am 2seventy bio GAAP EPS of -$3.20, revenue of $8.43M seekingalpha.com May 13, 2022 5:03 am
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress finance.yahoo.com May 12, 2022 4:05 pm
2seventy bio Presents New Preclinical Data on bbT369, an Investigational Dual-Targeting Gene-Edited CAR T Cell Therapy, at the AACR Annual Meeting finance.yahoo.com Apr 8, 2022 4:15 pm 2seventy bio GAAP EPS of -$2.55 beats by $0.80, revenue of $16.03M beats by $5.64M seekingalpha.com Mar 22, 2022 7:59 pm 2seventy bio receives $170M in private placement equity financing seekingalpha.com Mar 16, 2022 7:17 pm This company doesn't provide a dividend.
Talk about 2Seventy Bio Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!